Stock BNTX BIONTECH SE
Add to a list
To use this feature you must be a member
Log inSign up

News BioNTech SE

Equities

BNTX

US09075V1026

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
94.1 USD -2.94% Intraday chart for BioNTech SE +1.76% -10.84%
May. 28 European Equities Traded in the US as American Depositary Receipts Open Week Lower in Tuesday Trading MT
May. 28 BioNTech Collaborating with MediLink to Develop More Potential Antibody-Drug Conjugate, Immunotherapy Treatments MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Tuesday Trading
MT
BioNTech Collaborating with MediLink to Develop More Potential Antibody-Drug Conjugate, Immunotherapy Treatments
MT
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership
PR
European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower
MT
BIONTECH : Deutsche Bank remains Neutral
ZD
Health Care Up as Vaccine Makers Gain - Health Care Roundup
DJ
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
MT
BioNTech : to Evaluate NanoTag’s Target Labeling System in Different Therapeutic Areas
PU
Medigene, BioNTech Extend Cancer Immunotherapy Partnership
MT
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
GL
Sector Update: Health Care Stocks Mixed Late Afternoon
MT
Sector Update: Health Care Stocks Softer Friday Afternoon
MT
Sector Update: Health Care
MT
Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
MT
Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
MT
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program
MT
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot, FT reports
RE
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GL
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program
MT
Autolus Therapeutics' Q1 Loss Widens, Licensing Revenue Rises
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BNTX Stock
  4. News BioNTech SE